InsiderSignalSign in

← Insider buys

Scott D Sandell has bought stock on 38 days since Jan 2016

10% owner at Korro Bio, Inc., and 25 other companies

SEC CIK 0001237289 · Filings on SEC.gov ↗

$256.9MBought

$224.6MSold

Mar 12Last buy

Scott D Sandell's record

3 months after each buy, from the first price a copier could get.

−3.5%Average

−6.6 ptsVs S&P 500

2 of 6Higher

6 buys since 2016 with 3 months of prices.

Companies

Every filing

64 filings since Jan 2016, newest first

Korro Bio, Inc.

10% owner

$2.3M+19.0%Mar 12

Spyglass Pharma, Inc.

10% owner

$15.0M+15.0%Feb 11

Mbx Biosciences, Inc.

10% owner

$8.0M+16.0%Sep 17

Korro Bio, Inc.

10% owner

$1.0M+2.0%Apr 24

Cloudflare, Inc.

Director

$15.5M−49.0%Nov 22

Cloudflare, Inc.

Director

$1.3M−4.0%Aug 9

Savara Inc

10% owner

$1.0M+1.0%Jul 19

Glycomimetics Inc

10% owner

$11.5M−42.0%Jan 27

Glycomimetics Inc

10% owner

$197K−1.0%Jan 6

Glycomimetics Inc

10% owner

$1.2M−4.0%Jan 4

Cloudflare, Inc.

Director

$100K−1.0%Jun 16

Genocea Biosciences, Inc.

10% owner

$751K−100.0%May 26

Robinhood Markets, Inc.

Director

Trevi Therapeutics, Inc.

10% owner

$6.8M+46.0%Apr 13

Cloudflare, Inc.

Director

$701K−2.0%Feb 15

Robinhood Markets, Inc.

Director

Metacrine, Inc.

10% owner

$494K−16.0%Dec 27

Ardelyx, Inc.

10% owner

$3.6M−21.0%Dec 27

Marker Therapeutics, Inc.

10% owner

$10.0M+114.0%Mar 18

Regulus Therapeutics Inc.

10% owner

$2.7M+214.0%Dec 7

Cloudflare, Inc.

Director

$22.3M−10.0%Nov 20

Cloudflare, Inc.

Director

$29.4M−12.0%Nov 18

Cloudflare, Inc.

Director and 10% owner

$5.5M−2.0%Nov 13

Cloudflare, Inc.

Director and 10% owner

$17.6M−13.0%Aug 21

Cloudflare, Inc.

Director and 10% owner

$9.9M−7.0%Aug 18

Cloudflare, Inc.

Director and 10% owner

$23.6M−14.0%Aug 13

Cloudflare, Inc.

Director and 10% owner

$3.4M−2.0%Aug 10

Akouos, Inc.

10% owner

$10.0M+16.0%Jul 1

Ardelyx, Inc.

10% owner

$573K−1.0%Jun 12

Cloudflare, Inc.

Director and 10% owner

$9.6M−8.0%May 21

Mersana Therapeutics, Inc.

10% owner

Adaptimmune Therapeutics Plc

10% owner

$5.0M+8.0%Jan 28

Trevi Therapeutics, Inc.

10% owner

$25.0M+129.0%May 13

Regulus Therapeutics Inc.

10% owner

$1.2M+124.0%May 9

Aveo Pharmaceuticals Inc

10% owner

$5.0M+21.0%Apr 8

Aveo Pharmaceuticals Inc

10% owner

$774K+2.0%Dec 21

Aveo Pharmaceuticals Inc

10% owner

Aveo Pharmaceuticals Inc

10% owner

$338K+1.0%Dec 10

Aveo Pharmaceuticals Inc

10% owner

Aveo Pharmaceuticals Inc

10% owner

$336K+1.0%Nov 21

Aveo Pharmaceuticals Inc

10% owner

$2.2M+6.0%Nov 19

Adaptimmune Therapeutics Plc

10% owner

$25.0M+19.0%Sep 10

Aveo Pharmaceuticals Inc

10% owner

$1.5M+4.0%Aug 22

Bloom Energy Corp

Director and 10% owner

Aveo Pharmaceuticals Inc

10% owner

$492K+1.0%Jul 20

Glycomimetics Inc

10% owner

Aveo Pharmaceuticals Inc

10% owner

Surface Oncology, Inc.

10% owner

$2.0M+4.0%Apr 23

Aveo Pharmaceuticals Inc

10% owner

$2.1M+6.0%Apr 10

Adaptimmune Therapeutics Plc

10% owner

$12.6M+9.0%Mar 28

About Scott D Sandell

Scott D. Sandell is a prominent venture capitalist serving as Executive Chairman, Chief Investment Officer, and former CEO of New Enterprise Associates (NEA), one of the oldest and largest venture capital firms with over $12.5 billion raised during his tenure( Joining NEA as an Associate in 1996, he advanced to General Partner in 2000 and has led investments in transformative companies including Bloom Energy, Cloudflare, Robinhood, Salesforce, Tableau, and Workday, with 24 portfolio companies achieving public offerings or mergers(

Sandell began his career at the Boston Consulting Group, followed by roles as the first salesman at C-ATS Software (where he co-founded its European subsidiary), Product Manager at Microsoft on Windows 95, and consulting gigs before joining NEA( He holds an MBA from Stanford Graduate School of Business and an AB in Engineering Sciences from Dartmouth College( As a corporate insider, Sandell has been involved in recent trading activity at Spyglass Pharma, Inc. (SGP), reported at 10% ownership level, and serves on boards such as Lead Independent Director at Coursera, Inc.(

Written by Perplexity from public sources.

Filings come from SEC EDGAR. Not investment advice.